|
KIF23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.133900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.008300E-02 |
| Normal-vs-Stage2 |
8.176200E-01 |
| Normal-vs-Stage3 |
7.503600E-02 |
| Normal-vs-Stage4 |
3.249900E-02 |
| Stage1-vs-Stage2 |
5.208300E-04 |
| Stage1-vs-Stage3 |
7.621200E-01 |
| Stage1-vs-Stage4 |
5.063400E-01 |
| Stage2-vs-Stage3 |
1.074080E-02 |
| Stage2-vs-Stage4 |
5.864700E-03 |
| Stage3-vs-Stage4 |
4.307000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.880900E-03 |
| Normal-vs-AfricanAmerican |
5.908200E-01 |
| Normal-vs-Asian |
6.533900E-02 |
| Caucasian-vs-AfricanAmerican |
1.851440E-01 |
| Caucasian-vs-Asian |
8.813800E-01 |
| AfricanAmerican-vs-Asian |
2.609000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.904270E-02 |
| Normal-vs-Female |
7.439800E-02 |
| Male-vs-Female |
2.907000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.175400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.641600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.049200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.680000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.351700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.626000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.798770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.043000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.219900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.740170E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.386600E-01 |
| Classical-VS-Follicular |
7.79631914582524E-12 |
| Classical-VS-Other |
6.860600E-01 |
| Classical-VS-Normal |
1.878000E-03 |
| Tall-VS-Follicular |
1.057830E-03 |
| Tall-VS-Other |
6.251600E-01 |
| Tall-VS-Normal |
3.601900E-02 |
| Follicular-VS-Other |
5.883500E-02 |
| Follicular-VS-Normal |
3.209200E-01 |
| Other-VS-Normal |
4.456200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.363600E-01 |
| Normal-vs-N1 |
4.698100E-02 |
| N0-vs-N1 |
7.490200E-02 |
|
|
